Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Yoshimura, A

Class:IdPerson:205290
_displayNameYoshimura, A
_timestamp2007-12-10 09:59:34
created[InstanceEdit:205198] Garapati, P V, 2007-12-10 09:55:47
initialA
surnameYoshimura
(author)[LiteratureReference:205273] The adapter protein APS associates with the multifunctional docking sites Tyr-568 and Tyr-936 in c-Kit
[LiteratureReference:877270] Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain
[LiteratureReference:877309] The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop
[LiteratureReference:904806] A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors
[LiteratureReference:933430] TRAF6 and MEKK1 play a pivotal role in the RIG-I-like helicase antiviral pathway
[LiteratureReference:1112717] SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130
[LiteratureReference:1112736] The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling
[LiteratureReference:1675805] Cloning and characterization of a novel class II phosphoinositide 3-kinase containing C2 domain
[Change default viewing format]
No pathways have been reviewed or authored by Yoshimura, A (205290)